The Trader Times
The #1 source of information for traders- Stock research is the foundation for extraordinary stock market gains. The Trader Newspaper is published every trading day at 6 PM.
- Written by traders who became stock market millionaires themselves!
- Rankings of the best stocks (growth, accumulation, seasonal trends, sector leaders, pivotal points, ...)
Our magazine covers
SAP: The Current Price Weakness Could Provide Investors with a Buying Opportunity
Micron (MU) and Sandisk (SNDK): The Memory Champions Before a Multi-Year Bull Phase!
The true winner behind Google's TPU success: Why Broadcom is becoming indispensable!
Novo Nordisk: When the Stock Market Overreacts
Bayer AG: Is 2025 the Year of Change?
Chipotle: Why the Stock Belongs on Your Shopping List Now
Paramount: From Problem Child to Must-Have Subscription?
Tesla (TSLA) is Much More Than Just Electric Cars – The Underestimated Strength in AI Chip Design!
RadNet: AI Study and GE HealthCare Partnership as new Drivers
Medpace: The True Winner in Healthcare Thanks to AI and Quantum Computers?
1
SAP: The Current Price Weakness Could Provide Investors with a Buying Opportunity
2
Micron (MU) and Sandisk (SNDK): The Memory Champions Before a Multi-Year Bull Phase!
3
Artificial Intelligence Drives Billion-Dollar Rally: Winners and Losers in the Semiconductor Poker!
4
Natera: How the Diagnostics Pioneer is Redefining the Cancer Market with Cell-Free DNA
5
Meta Examines Billion-Dollar Deal for Google TPUs, and Google's New AI Model Gemini 3 Relies Specifically on These Chips
6
The new Week Starts with Signs of Recovery – Rate cut Fantasies, Ukraine Hopes, and Strong Travel Trends Support Investor Sentiment – Alphabet Drives Stock Market Rally – Hope for China Business Stabilizes NVIDIA – Tesla Confirms its own AI Chip Business – DAX Stabilizes, but ifo Data Weighs on Sentiments – Bayer Reports Study Success – Defense Stocks Decline
7
Waymo's Robotaxis are Expanding all Across California
8
Meta Aims to Meet its AI Energy Needs Through Electricity Trading
9
Eli Lilly: New $1 Trillion Giant! Weight Loss Drugs Propel the Pharma Heavyweight to new Heights!
10
Microsoft's AI Dilemma! The Tech Giant Suddenly has to Fight for Every Customer Despite a Massive Lead!
1
NVIDIA under pressure from Google's offensive in the AI semiconductor market – Investors between interest rate hopes and competition concerns – Robotaxi pioneer Pony.ai faces huge growth spike - Klarna with stablecoin offensive - DAX recovers after peace signals in the Ukraine conflict – Construction and defense stocks benefit, Thyssenkrupp Nucera crashes!
2
Top Breakout Candidate Medpace: Beneficiary of AI and Quantum Computers, Breaking Out from the Pivotal Base!
3
Stocks in Action USA: Abercrombie & Fitch, Kohl’s, Keysight Technologies
4
Exclusive from EK Forum II: Porr can achieve double-digit margins with data centers. But what about the Ukraine reconstruction opportunity?
5
Exclusive from the EK Forum: These are the three growth markets for Kontron. Why there is a great opportunity for a positive surprise in cybersecurity!
6
ArriVent Biopharma: Truist Securities recommends buying with a price target of $43!
7
SAP: The Current Price Weakness Could Provide Investors with a Buying Opportunity
8
Pivotal-Point Tracking The Goodyear Tire & Rubber Company (GT): EPS rises to $0.28 in Q3 - Margins improve due to focus on premium tires!
9
Pivotal-Point Tracking Guardant Health (GH): 39% Revenue Growth in Q3 and Increased Annual Guidance in {[Oncology!]}
10
Natera - Attractive Treatment Numbers Drive Momentum!
ArriVent BioPharma
Top Growth Stocks by Revenue and Earnings
| Rank | Stock | Price | Rev. Gr. | Dist. 52WH | Perf. 20D |
|---|---|---|---|---|---|
| WKN | Symbol | EPS Growth | Rel. Strength | |||
| 1 | Verisk Analytics | 278.09 $ | 26.37 % | 9.32 % | -3.45 % |
| A0YA2M | VRSK | 88.86 % | 86 | |||
| 2 | Palomar Holdings | 130.13 $ | 40.22 % | 9.49 % | -0.24 % |
| A2PHB6 | PLMR | 49.48 % | 96 | |||
| 3 | HCI Group | 137.14 $ | 49.16 % | 9.70 % | -1.56 % |
| A1W02H | HCI | 199.39 % | 85 | |||
| 4 | Progressive | 259.68 $ | 22.67 % | 11.37 % | -6.44 % |
| 865496 | PGR | 198.70 % | 88 | |||
| 5 | Universal Technical Institute | 26.47 $ | 20.63 % | 13.39 % | -1.64 % |
| 590097 | UTI | 533.33 % | 96 | |||
| 6 | Halozyme Therapeutics | 56.53 $ | 21.35 % | 14.34 % | -7.15 % |
| A0DLHS | HALO | 60.73 % | 92 | |||
| 7 | Insulet | 246.49 $ | 27.42 % | 14.84 % | -0.76 % |
| A0MQX8 | PODD | 250.00 % | 92 | |||
| 8 | Interdigital | 192.19 $ | 28.53 % | 17.15 % | -9.55 % |
| A0MWY3 | IDCC | 41.33 % | 98 | |||
| 9 | Tradeweb Markets | 122.34 $ | 29.44 % | 19.86 % | -8.22 % |
| TW | 20.69 % | 84 | |||
| 10 | Catalyst Pharmaceuticals | 20.86 $ | 32.17 % | 20.27 % | -1.62 % |
| A0LCUL | CPRX | 111.86 % | 90 |
